Table 1.
n | Percentage (%) | |
---|---|---|
Type | ||
Generic | 386 | 50.1 |
HIV‐specific | 384 | 49.9 |
Country income level | ||
High | 344 | 44.7 |
Upper‐middle | 232 | 30.0 |
Lower‐middle | 119 | 15.4 |
Low | 63 | 8.2 |
Mix | 13 | 1.7 |
World region | ||
African | 164 | 21.3 |
Americas | 248 | 32.2 |
Eastern Mediterranean | 22 | 2.9 |
European | 131 | 17.0 |
South‐East Asian | 73 | 9.5 |
Western Pacific | 108 | 14.0 |
Mix | 24 | 3.1 |
Study design | ||
RCT | 110 | 14.3 |
Observational | 505 | 65.6 |
Cohort | 138 | 17.9 |
Economic evaluation | 17 | 2.2 |
Study setting | ||
Hospital | 405 | 52.6 |
Community/GP | 219 | 28.4 |
NGO/peer‐led | 32 | 4.2 |
Others | 84 | 10.9 |
Unclear | 30 | 3.9 |
Target population | ||
PLHIV versus non‐PLHIV | 78 | 10.1 |
PLHIV only | 692 | 89.9 |
Sub‐population characteristics |
||
Women | 68 | 8.8 |
MSM | 28 | 3.6 |
Mixed population (except women and MSM) | 674 | 87.5 |